Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
NPJ Precision Oncology|October 2, 2023
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancerNicholas P Semenkovich, Shahed N Badiyan, Pamela P Samson, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLCPragya Kumar, Menkara Henry, Julia Pelesko, et al.
International Journal of Molecular Sciences|February 11, 2023
Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung CancerAlex C Soupir, Yijun Tian, Paul A Stewart, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2024
Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung AdenocarcinomaHilal Ozakinci, Xiaofei Song, Gina S Nazario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung CancerBruna Pellini, Russell W Madison, Merrida A Childress, et al.
Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
JCO Precision Oncology|July 12, 2021
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and UrineBruna Pellini, Nadja Pejovic, Wenjia Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)Xiuning Le, Jyoti D Patel, Elaine Shum, et al.
Pageof 5